{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:23:28Z","timestamp":1767961408894,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[1992,10,1]],"date-time":"1992-10-01T00:00:00Z","timestamp":717897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[1992,10]]},"DOI":"10.1007\/bf01973382","type":"journal-article","created":{"date-parts":[[2005,8,3]],"date-time":"2005-08-03T16:00:48Z","timestamp":1123084848000},"page":"525-537","source":"Crossref","is-referenced-by-count":37,"title":["Cephaloridine-induced nephrotoxicity in the Fischer 344 rat: proton NMR spectroscopic studies of urine and plasma in relation to conventional clinical chemical and histopathological assessments of nephronal damage"],"prefix":"10.1007","volume":"66","author":[{"given":"Maria L.","family":"Anthony","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin P. R.","family":"Gartland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"Beddell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Lindon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy K.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01973382_CR1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0041-008X(66)90051-2","volume":"8","author":"RM Atkinson","year":"1966","unstructured":"Atkinson RM, Caisey JD, Currie JP, Middleton TR, Pratt DAH, Sharpe HM, Tomich EG (1966) Subacute toxicity of cephaloridine to various species. Toxicol Appl Pharmacol 8: 407\u2013428","journal-title":"Toxicol Appl Pharmacol"},{"issue":"25","key":"BF01973382_CR2","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1021\/bi00670a037","volume":"15","author":"UM Babu","year":"1976","unstructured":"Babu UM, Johnston RB (1976) Nuclear magnetic resonance studies of D20-substrate exchange reactions catalysed by glutamic pyruvic and glutamic oxaloacetic transaminases. Biochemistry 15 [25]: 5671\u20135678","journal-title":"Biochemistry"},{"key":"BF01973382_CR3","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/clinchem\/30.3.426","volume":"30","author":"JR Bales","year":"1984","unstructured":"Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ (1984) Use of high resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem 30: 426\u2013432","journal-title":"Clin Chem"},{"key":"BF01973382_CR4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/mrm.1910030605","volume":"3","author":"JR Bales","year":"1986","unstructured":"Bales JR, Bell JD, Nicholson JK, Sadler PJ (1986)1H NMR studies of urine during fasting: excretion of ketone bodies and acetylcarnitine. Mag Reson Med 3: 849\u2013856","journal-title":"Mag Reson Med"},{"key":"BF01973382_CR5","first-page":"F257","volume":"249","author":"M Barac-Nieto","year":"1985","unstructured":"Barac-Nieto M (1985) Renal hydroxybutyrate and acetoacetate reabsorption and utilisation in the rat. Am J Physiol 249: F257-F265","journal-title":"Am J Physiol"},{"key":"BF01973382_CR6","first-page":"108","volume":"26","author":"KJ Child","year":"1966","unstructured":"Child KJ, Dodds MG (1966) Mechanism of urinary excretion of cephaloridine and its effects on renal function in animals. Br J Pharmacol 26: 108\u2013119","journal-title":"Br J Pharmacol"},{"key":"BF01973382_CR7","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0272-0590(83)80140-7","volume":"3","author":"C Cojocel","year":"1983","unstructured":"Cojocel C, Smith JH, Maita K, Sleight SD, Hook JB (1983) Renal protein degradation: a biochemical target of specific nephrotoxicants. Fundam Appl Tox 3: 278\u2013284","journal-title":"Fundam Appl Tox"},{"key":"BF01973382_CR8","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0005-2760(85)90014-1","volume":"834","author":"C Cojocel","year":"1985","unstructured":"Cojocel C, Hannemann J, Baumann K (1985) Cephaloridine-induced lipid peroxidation initiated by reactive oxygen species as a possible mechanism of cephaloridine nephrotoxicity. Biochem Biophys Acta 834: 402\u2013410","journal-title":"Biochem Biophys Acta"},{"key":"BF01973382_CR9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jac\/1.suppl_3.119","volume":"1","author":"RD Foord","year":"1975","unstructured":"Foord RD (1975) Cephaloridine, cephalothin and the kidney. J Antimicrob Chemother 1: 119","journal-title":"J Antimicrob Chemother"},{"key":"BF01973382_CR10","doi-asserted-by":"crossref","unstructured":"Foxall PJD, Mellotte GJ, Bending MR, Lindon JC, Nicholson JK (1992) High resolution proton nuclear magnetic resonance spectroscopy of urine as a novel approach to the monitoring of renal transplant function. Kidney Int (in press)","DOI":"10.1038\/ki.1993.37"},{"key":"BF01973382_CR11","first-page":"242","volume":"35","author":"KPR Gartland","year":"1989","unstructured":"Gartland KPR, Bonner FW, Nicholson JK (1989 a) Investigations into the biochemical effects of region-specific nephrotoxins. Mol Pharmacol 35: 242\u2013250","journal-title":"Mol Pharmacol"},{"key":"BF01973382_CR12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00316430","volume":"63","author":"KPR Gartland","year":"1989","unstructured":"Gartland KPR, Bonner FW, Timbrell JA, Nicholson JK (1989 b) Biochemical characterisation of para-aminophenol-induced nephrotoxic lesions in the F344 rat. Arch Toxicol 63: 97\u2013106","journal-title":"Arch Toxicol"},{"issue":"8\u201312","key":"BF01973382_CR13","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0731-7085(90)80148-I","volume":"8","author":"KPR Gartland","year":"1990","unstructured":"Gartland KPR, Anthony ML, Beddell CR, Lindon JC, Nicholson JK (1990) PMR studies on the effects of uranyl nitrate on the biochemical composition of rat urine and plasma. J Pharm Biomed Anal 8 [8\u201312]: 951\u2013954","journal-title":"J Pharm Biomed Anal"},{"key":"BF01973382_CR14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0300-483X(86)90171-X","volume":"38","author":"RS Goldstein","year":"1986","unstructured":"Goldstein RS, Pasino DA, Hook JB (1986) Cephaloridine nephrotoxicity in aging male Fischer-344 rats. Toxicology 38: 43\u201353","journal-title":"Toxicology"},{"key":"BF01973382_CR15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0041-008X(87)90291-2","volume":"87","author":"RS Goldstein","year":"1987","unstructured":"Goldstein RS, Contardi LR, Pasino DA, Hook JB (1987) Mechanisms mediating cephaloridine inhibition of renal gluconeogenesis. Toxicol Appl Pharmacol 87: 297\u2013305","journal-title":"Toxicol Appl Pharmacol"},{"key":"BF01973382_CR16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1103\/PhysRev.80.580","volume":"80","author":"EL Hahn","year":"1950","unstructured":"Hahn EL (1950) Spin echoes. Physics Rev 80: 580\u2013594","journal-title":"Physics Rev"},{"issue":"12","key":"BF01973382_CR17","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/0006-2952(91)90150-4","volume":"41","author":"MP Harrison","year":"1991","unstructured":"Harrison MP, Jones DV, Pickford RJ, Wilson ID (1991) \u03b2-Hydroxybutyrate: a urinary marker of imipenem induced nephrotoxicity in the cynomolgus monkey detected by high field1H NMR spectroscopy. Biochem Pharmacol 41 [12]: 2045\u20132049","journal-title":"Biochem Pharmacol"},{"key":"BF01973382_CR18","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0731-7085(90)80149-J","volume":"8","author":"E Holmes","year":"1990","unstructured":"Holmes E, Foxall PJD, Nicholson JK (1990) Proton NMR analysis of plasma from renal failure patients: evaluation of sample preparation and spectral-editing methods. J Pharm Biomed Anal 8: 955\u2013958","journal-title":"J Pharm Biomed Anal"},{"key":"BF01973382_CR19","first-page":"E168","volume":"243","author":"CL Hoppel","year":"1982","unstructured":"Hoppel CL, Genuth SM (1982) Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis. Am J Physiol 243: E168-E172","journal-title":"Am J Physiol"},{"key":"BF01973382_CR20","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1172\/JCI109182","volume":"62","author":"K Kida","year":"1978","unstructured":"Kida K, Nakajo S, Kamija F, Nishio T, Nakagawa H (1978) Renal net glucose release in vivo and its contribution to blood glucose in rats. J Clin Invest 62: 721\u2013726","journal-title":"J Clin Invest"},{"key":"BF01973382_CR21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0041-008X(82)90052-7","volume":"63","author":"CH Kuo","year":"1982","unstructured":"Kuo CH, Hook JB (1982) Depletion of renal glutathione content and nephrotoxicity of cephaloridine in rabbits, rats and mice. Toxicol Appl Pharmacol 63: 292\u2013302","journal-title":"Toxicol Appl Pharmacol"},{"key":"BF01973382_CR22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0041-008X(83)90246-6","volume":"67","author":"CH Kuo","year":"1983","unstructured":"Kuo CH, Maita K, Sleight SD, Hook JB (1983) Lipid peroxidation: a possible mechanism of cephaloridine-induced nephrotoxicity. Toxicol Appl Pharmacol 67: 78\u201388","journal-title":"Toxicol Appl Pharmacol"},{"key":"BF01973382_CR23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Dandall RJ (1951) Protein measurement with the Folin-phenol reagent. J Biol Chem 193: 265\u2013275","journal-title":"J Biol Chem"},{"key":"BF01973382_CR24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0041-008X(77)90005-9","volume":"42","author":"RJ McMurtry","year":"1977","unstructured":"McMurtry RJ, Mitchell JR (1977) Renal and hepatic necrosis after metabolic activation of 2-substituted furans and thiophenes, including furosemide and cephaloridine. Toxicol Appl Pharmacol 42: 285\u2013300","journal-title":"Toxicol Appl Pharmacol"},{"key":"BF01973382_CR25","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0272-0590(83)80102-X","volume":"3","author":"H Miyajima","year":"1983","unstructured":"Miyajima H, Hewitt WR, Cote MG, Plaa GL (1983) Relationships between histological and functional indices of acute chemically induced nephrotoxicity. Fundam Appl Toxicol 3: 543\u2013551","journal-title":"Fundam Appl Toxicol"},{"key":"BF01973382_CR26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/096032719201100105","volume":"11","author":"LB Murgatroyd","year":"1992","unstructured":"Murgatroyd LB, Pickford R, Smith IK, Wilson ID (1992)1H NMR spectroscopy as a means of monitoring nephrotoxicity as exemplified by studies with cephaloridine. Hum Exp Toxicol 11: 35\u201341","journal-title":"Hum Exp Toxicol"},{"key":"BF01973382_CR27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/978-1-4684-1283-3_42","volume-title":"Cells, membranes and disease, including renal. Methodological surveys in biochemistry and analysis. Vol 17","author":"JK Nicholson","year":"1987","unstructured":"Nicholson JK, Gartland KPR (1987) A nuclear magnetic resonance approach to investigate the biochemical and molecular effects of nephrotoxins. In: Reid E, Cook GMW, Luzio JP (eds) Cells, membranes and disease, including renal. Methodological surveys in biochemistry and analysis. Vol 17. Plenum Press, New York, pp 397\u2013408"},{"key":"BF01973382_CR28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0079-6565(89)80008-1","volume":"21","author":"JK Nicholson","year":"1989","unstructured":"Nicholson JK, Wilson ID (1989) High resolution proton magnetic resonance spectroscopy of biological fluids. Progress in NMR Spectroscopy 21: 449\u2013501","journal-title":"Progress in NMR Spectroscopy"},{"key":"BF01973382_CR29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/bj2170365","volume":"217","author":"JK Nicholson","year":"1984","unstructured":"Nicholson JK, O'Flynn MP, Sadler PJ, Macleod AF, Juul SM, Sonksen PH (1984) Proton nuclear magnetic resonance studies of serum, plasma and urine from fasting, normal and diabetic subjects. Biochem J 217: 365\u2013375","journal-title":"Biochem J"},{"key":"BF01973382_CR30","first-page":"644","volume":"27","author":"JK Nicholson","year":"1985","unstructured":"Nicholson JK, Timbrell JA, Sadler PJ (1985) Proton NMR spectra of urine as indicators of renal damage: Mercury-induced nephrotoxicity in rats. Mol Pharmacol 27: 644\u2013651","journal-title":"Mol Pharmacol"},{"key":"BF01973382_CR31","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diab.30.6.510","volume":"30","author":"O Owen","year":"1981","unstructured":"Owen O, Licht JH, Sapir DG (1981) Renal function and effects of partial rehydration during diabetic ketoacidosis. Diabetes 30: 510\u2013518","journal-title":"Diabetes"},{"key":"BF01973382_CR32","first-page":"371","volume-title":"Bioanalysis of drugs and metabolites","author":"R Pickford","year":"1988","unstructured":"Pickford R, Smith IK, Wilson ID (1988) A note on urinalysis by1H NMR, application to cephaloridine treated rats. In: Reid E, Robinson JD, Wilson ID (eds) Bioanalysis of drugs and metabolites. Plenum Publishing Corporation, New York, pp 371\u2013374"},{"key":"BF01973382_CR33","first-page":"377","volume":"26","author":"W Raab","year":"1976","unstructured":"Raab W, Moerth C (1976) Renal effects of gentamycin and cephaloridine-evaluation by renal enzyme excretion studies in rats and comparison with other antibiotics. Arzneimittelforschung 26: 377\u2013379","journal-title":"Arzneimittelforschung"},{"key":"BF01973382_CR34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0026-0495(75)90004-9","volume":"24","author":"DG Sapir","year":"1975","unstructured":"Sapir DG, Owen O (1975) Renal conservation of ketone bodies during starvation. Metabolism 24: 23\u201333","journal-title":"Metabolism"},{"key":"BF01973382_CR35","doi-asserted-by":"crossref","unstructured":"Stewart GT, Holt RJ (1964) Laboratory and clinical results with cephaloridine. Lancet 1305\u20131309","DOI":"10.1016\/S0140-6736(64)91102-X"},{"key":"BF01973382_CR36","first-page":"250","volume":"181","author":"BM Tune","year":"1972","unstructured":"Tune BM (1972) Effect of organic acid transport inhibitors on renal cortical uptake and proximal tubular toxicity of cephaloridine. J Pharmacol Exp Ther 181: 250\u2013256","journal-title":"J Pharmacol Exp Ther"},{"key":"BF01973382_CR37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/infdis\/132.2.189","volume":"132","author":"BM Tune","year":"1975","unstructured":"Tune BM (1975) Relationship between the transport and toxicity of cephalosporins in the kidney. J Infect Dis 132: 189\u2013194","journal-title":"J Infect Dis"},{"key":"BF01973382_CR38","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1152\/ajplegacy.1973.225.5.1114","volume":"225","author":"BM Tune","year":"1973","unstructured":"Tune BM, Fernholt M (1973) Relationship between cephaloridine andp-aminohippurate transport in the kidney. Am J Physiol 225: 1114\u20131117","journal-title":"Am J Physiol"},{"key":"BF01973382_CR39","first-page":"472","volume":"202","author":"BM Tune","year":"1977","unstructured":"Tune BM, Wu KY, Longerbeam DF, Kempson RL (1977) Transport and toxicity of cephaloridine in the kidney. Effect of furosemide,p-aminohippurate and saline diuresis. J Pharmacol Exp Ther 202: 472\u2013478","journal-title":"J Pharmacol Exp Ther"},{"key":"BF01973382_CR40","first-page":"98","volume":"210","author":"BM Tune","year":"1979","unstructured":"Tune BM, Wu KY, Fravert D, Holtzmann D (1979) Effect of cephaloridine on respiration by renal mitochondria. J Pharmacol Exp Ther 210: 98\u2013100","journal-title":"J Pharmacol Exp Ther"},{"key":"BF01973382_CR41","first-page":"1054","volume":"245","author":"BM Tune","year":"1987","unstructured":"Tune BM, Sibley RK, Hsu CY (1987) The mitochondrial respiratory toxicity of cephalosporin antibiotics. An inhibitory effect on substrate uptake. J Pharmacol Exp Ther 245: 1054\u20131059","journal-title":"J Pharmacol Exp Ther"},{"key":"BF01973382_CR42","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0006-2952(89)90233-5","volume":"38","author":"BM Tune","year":"1989","unstructured":"Tune BM, Fravert D, Hsu CY (1989) The oxidative and mitochondrial toxic effects of cephalosporin antibiotics in the kidney. A comparative study of cephaloridine and cephaloglycin. Biochem Pharmacol 38: 795\u2013802","journal-title":"Biochem Pharmacol"},{"key":"BF01973382_CR43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0300-483X(89)90165-0","volume":"57","author":"MA Valentovic","year":"1989","unstructured":"Valentovic MA, Ball JG, Elliott C, Madan E (1989) Cephaloridine nephrotoxicity in streptozotocin induced diabetic F344 rats. Toxicology 57: 193\u2013207","journal-title":"Toxicology"},{"key":"BF01973382_CR44","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/bmj.282.6267.849","volume":"282","author":"NM Wilson","year":"1981","unstructured":"Wilson NM, Brown PM, Juul SM, Prestwich SA, Sonksen PH (1981) Glucose turnover and metabolic and hormonal changes in ethanol-induced hypoglycaemia. BMJ 282: 849\u2013853","journal-title":"BMJ"},{"key":"BF01973382_CR45","first-page":"203","volume":"9","author":"G Wirthensohn","year":"1983","unstructured":"Wirthensohn G, Guder WG (1983) Renal lipid metabolism. Mineral Elect Metab 9: 203\u2013211","journal-title":"Mineral Elect Metab"},{"key":"BF01973382_CR46","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0021-9673(00)83009-5","volume":"136","author":"JS Wold","year":"1977","unstructured":"Wold JS, Turnipseed SA (1977) Determination of cephaloridine in serum and tissue by high-performance liquid chromatography. J Chromatograph 136: 170","journal-title":"J Chromatograph"},{"key":"BF01973382_CR47","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/0024-3205(80)90539-1","volume":"27","author":"JS Wold","year":"1980","unstructured":"Wold JS, Turnipseed SA (1980) The effect of renal cation transport inhibitors on the in vivo and in vitro accumulation and efflux of cephaloridine. Life Sci 27: 2559\u20132564","journal-title":"Life Sci"},{"key":"BF01973382_CR48","first-page":"778","volume":"201","author":"JS Wold","year":"1977","unstructured":"Wold JS, Joost RR, Owen NV (1977) Nephrotoxicity of cephaloridine in newborn rabbits: role of the renal anionic transport system. J Pharmacol Exp Ther 201: 778\u2013785","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01973382.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01973382\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01973382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T17:17:57Z","timestamp":1626283077000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01973382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,10]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1992,10]]}},"alternative-id":["BF01973382"],"URL":"https:\/\/doi.org\/10.1007\/bf01973382","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,10]]}}}